BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/25/2026 7:48:59 AM | Browse: 2 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 120606
Country United States
Category Oncology
Manuscript Type Editorial
Article Title Imaging tumor heterogeneity to predict response to transarterial chemoembolization in hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Arunkumar Krishnan
Funding Agency and Grant Number
Corresponding Author Arunkumar Krishnan, MD, Department of Supportive Oncology, Atrium Health Levine Cancer, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, 1021 Morehead Medical Dr, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com
Key Words Hepatocellular carcinoma; Transarterial chemoembolization; Intratumoral heterogeneity; Habitat imaging; Magnetic resonance imaging; Radiomics; Predictive modeling; Personalized medicine
Core Tip The study by Lv et al integrated contrast-enhanced magnetic resonance imaging-derived habitat features, conventional radiomics, and clinical variables to predict early response to transarterial chemoembolization in hepatocellular carcinoma, achieving area under the curve values of 0.97 and 0.93 in the training and validation cohorts, respectively. While the ecological diversity index and multicenter design are meaningful advancements, several key methodological issues remain unresolved: Feature selection outside nested cross-validation, which risks data leakage and overly optimistic performance estimates; confounding from mixed protocols; outcome misclassification due to the use of both computed tomography and magnetic resonance imaging follow-up; and insufficient inter-site harmonization. Prospective validation, integration of multi-sequence imaging, and studies analyzing the impact on decision-making are necessary before implementing this in clinical practice.
Citation Krishnan A. Imaging tumor heterogeneity to predict response to transarterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 2026; In press
Received
2026-03-03 03:14
Peer-Review Started
2026-03-03 03:15
First Decision by Editorial Office Director
2026-04-17 08:11
Return for Revision
2026-04-17 08:11
Revised
2026-04-20 17:15
Publication Fee Transferred
Second Decision by Editor
2026-05-25 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-25 07:48
Articles in Press
2026-05-25 07:48
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com